The ultimate fate of a stem or progenitor cell in a woman’s breast — whether the cell develops normally or whether it turns cancerous — may depend upon signals from multiple microenvironments. New results suggest that modulations of microenvironmental signals are a promising pathway for future cancer and regenerative medicine therapies.